blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0797664

EP0797664 - USE OF A HUMAN INTERLEUKIN-11 RECEPTOR [Right-click to bookmark this link]
Former [1997/40]HUMAN INTERLEUKIN-11 RECEPTOR
[2005/12]
StatusNo opposition filed within time limit
Status updated on  14.09.2007
Database last updated on 17.09.2024
Most recent event   Tooltip19.06.2009Lapse of the patent in a contracting state
New state(s): FR
published on 22.07.2009  [2009/30]
Applicant(s)For all designated states
Genetics Institute, LLC
87 Cambridge Park Drive
Cambridge, MA 02140 / US
[2002/26]
Former [1997/40]For all designated states
GENETICS INSTITUTE, INC.
87 Cambridge Park Drive
Cambridge, Massachusetts 02140 / US
Inventor(s)01 / TOBIN, James F.
78 Clearwater Road
Newton, MA 02162 / US
[1997/40]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1997/40]VOSSIUS & PARTNER
Postfach 86 07 67
81634 München / DE
Application number, filing date95942913.527.11.1995
[1997/40]
WO1995US15400
Priority number, dateUS1994036230422.12.1994         Original published format: US 362304
[1997/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9619574
Date:27.06.1996
Language:EN
[1996/29]
Type: A1 Application with search report 
No.:EP0797664
Date:01.10.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 27.06.1996 takes the place of the publication of the European patent application.
[1997/40]
Type: B1 Patent specification 
No.:EP0797664
Date:18.10.2006
Language:EN
[2006/42]
Search report(s)International search report - published on:EP27.06.1996
ClassificationIPC:C12N15/12, C07K14/715, A61K38/17, C07K16/28, C12N5/10, A61K39/395, G01N33/68
[1997/40]
CPC:
C07K14/7155 (EP,US); A61P15/10 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P31/04 (EP); A61P31/12 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/04 (EP);
A61P43/00 (EP); A61P7/06 (EP); C07K14/715 (EP,US);
A61K38/00 (EP,US); G01N2500/02 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/40]
TitleGerman:VERWENDUNG EINES MENSCHLICHEN INTERLEUKIN-11 REZEPTORS[2005/12]
English:USE OF A HUMAN INTERLEUKIN-11 RECEPTOR[2005/12]
French:UTILISATION D'UN RECEPTEUR DE L'INTERLEUKINE-11 HUMAINE[2005/12]
Former [1997/40]MENSCHLICHES INTERLEUKIN-11 REZEPTOR
Former [1997/40]HUMAN INTERLEUKIN-11 RECEPTOR
Former [1997/40]RECEPTEUR DE L'INTERLEUKINE-11 HUMAINE
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase22.07.1997National basic fee paid 
22.07.1997Designation fee(s) paid 
22.07.1997Examination fee paid 
Examination procedure10.07.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.07.1997Examination requested  [1997/40]
06.05.2003Despatch of a communication from the examining division (Time limit: M07)
20.01.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
30.03.2004Reply to a communication from the examining division
12.10.2004Date of oral proceedings
08.11.2004Despatch of a communication from the examining division (Time limit: M02)
08.11.2004Minutes of oral proceedings despatched
18.01.2005Reply to a communication from the examining division
21.11.2005Communication of intention to grant the patent
31.03.2006Fee for grant paid
31.03.2006Fee for publishing/printing paid
Divisional application(s)EP04024209.1  / EP1566440
Opposition(s)19.07.2007No opposition filed within time limit [2007/42]
Request for further processing for:30.03.2004Request for further processing filed
30.03.2004Full payment received (date of receipt of payment)
Request granted
15.04.2004Decision despatched
Fees paidRenewal fee
28.11.1997Renewal fee patent year 03
27.11.1998Renewal fee patent year 04
30.11.1999Renewal fee patent year 05
10.11.2000Renewal fee patent year 06
07.11.2001Renewal fee patent year 07
07.11.2002Renewal fee patent year 08
07.11.2003Renewal fee patent year 09
08.11.2004Renewal fee patent year 10
07.11.2005Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.10.2006
BE18.10.2006
IE27.11.2006
LU27.11.2006
ES28.11.2006
SE28.11.2006
CH30.11.2006
FR30.11.2006
LI30.11.2006
MC30.11.2006
GB18.01.2007
GR19.01.2007
DK31.01.2007
PT19.03.2007
DE01.06.2007
NL01.06.2007
[2009/30]
Former [2008/36]AT18.10.2006
BE18.10.2006
IE27.11.2006
LU27.11.2006
ES28.11.2006
SE28.11.2006
CH30.11.2006
LI30.11.2006
MC30.11.2006
GB18.01.2007
GR19.01.2007
DK31.01.2007
PT19.03.2007
DE01.06.2007
NL01.06.2007
Former [2008/24]AT18.10.2006
BE18.10.2006
IE27.11.2006
ES28.11.2006
SE28.11.2006
CH30.11.2006
LI30.11.2006
MC30.11.2006
GB18.01.2007
GR19.01.2007
DK31.01.2007
PT19.03.2007
DE01.06.2007
NL01.06.2007
Former [2008/21]AT18.10.2006
BE18.10.2006
IE27.11.2006
SE28.11.2006
CH30.11.2006
LI30.11.2006
MC30.11.2006
GB18.01.2007
GR19.01.2007
DK31.01.2007
PT19.03.2007
DE01.06.2007
NL01.06.2007
Former [2008/08]AT18.10.2006
BE18.10.2006
IE27.11.2006
SE28.11.2006
CH30.11.2006
LI30.11.2006
MC30.11.2006
GB18.01.2007
DK31.01.2007
PT19.03.2007
DE01.06.2007
NL01.06.2007
Former [2008/06]AT18.10.2006
BE18.10.2006
IE27.11.2006
SE28.11.2006
CH30.11.2006
LI30.11.2006
MC30.11.2006
GB18.01.2007
PT19.03.2007
DE01.06.2007
NL01.06.2007
Former [2007/31]AT18.10.2006
BE18.10.2006
PT19.03.2007
Former [2007/29]AT18.10.2006
PT19.03.2007
Cited inInternational search[X]  - H. NEUHAUS ET AL, "Etl2, a novel putative type-I cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential", DEVELOPMENTAL BIOLOGY, (1994), vol. 166, pages 531 - 542, XP002000295 [X] 1,4-9,29,30 *see the whole document especially figure 3 page 535 *

DOI:   http://dx.doi.org/10.1006/dbio.1994.1335
 [X]  - D.J. HILTON ET AL, "Cloning of a murine IL-11 receptor alpha-chain ; requirement for gp130 for high affinity binding and signal transduction", EMBO JOURNAL, EYNSHAM, OXFORD GB, (19941017), vol. 13, no. 20, pages 4765 - 4775, XP002000296 [X] 1,4-9,29,30 * page 4766, column R, line 9 - line 37 * * page 4769, column R, line 17 - line 20 * * figure 1 *
 [PX]  - M. CHEREL ET AL, "Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine Interleukin-11", BLOOD, (19951001), vol. 86, no. 7, pages 2534 - 2540, XP002000297 [PX] 1,2,4-9,29,30 * the whole document *
 [A]  - M. FOURCIN ET AL, "Involvement of gp130/interleukin-6 receptor transducing component in Interleukin-11 receptor", EUROPEAN JOURNAL OF IMMUNOLOGY, (199401), vol. 24, no. 1, pages 277 - 280, XP002000298 [A] 19,20 * page 278, column R - page 279 *

DOI:   http://dx.doi.org/10.1002/eji.1830240143
 [A]  - YU-CHUNG YANG ET AL, "Interleukin-11 and its receptor", BIOFACTORS, (199212), vol. 4, no. 1, pages 15 - 21, XP002000299 [A] 13-15,19 * page 17 - page 18 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.